CoChat
Sign Up
Cited by 727HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskMental Health Treatment and Access

Mental health and HIV/AIDS: the need for an integrated response

Open access
Remien, Robert H., Stirratt, Michael J., Nguyen, Nadia, Robbins, Reuben N., Pala, Andrea N., Mellins, Claude A.·2019·AIDS
DOI 10.1097/qad.0000000000002227PMC PMC6635049
Open this paper in CoChat — free account

Abstract

: Tremendous biomedical advancements in HIV prevention and treatment have led to aspirational efforts to end the HIV epidemic. However, this goal will not be achieved without addressing the significant mental health and substance use problems among people living with HIV (PLWH) and people vulnerable to acquiring HIV. These problems exacerbate the many social and economic barriers to accessing adequate and sustained healthcare, and are among the most challenging barriers to achieving the end of the HIV epidemic. Rates of mental health problems are higher among both people vulnerable to acquiring HIV and PLWH, compared with the general population. Mental health impairments increase risk for HIV acquisition and for negative health outcomes among PLWH at each step in the HIV care continuum. We have the necessary screening tools and efficacious treatments to treat mental health problems among people living with and at risk for HIV. However, we need to prioritize mental health treatment with appropriate resources to address the current mental health screening and treatment gaps. Integration of mental health screening and care into all HIV testing and treatment settings would not only strengthen HIV prevention and care outcomes, but it would additionally improve global access to mental healthcare.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0000000000002227

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIV-related stigma can compromise health behaviours such as adherence to antiretroviral therapy among people living with HIV.

    “PLWH also experience HIV-related stigma which exacerbates mental health problems (Levi-Minzi & Surratt, 2014) and can compromise health behaviours such as adherence to life-saving antiretroviral therapy (ART) (Remien et al., 2019; Uthman et al., 2014).”

    From Resilience resources for mental health among people living with HIV: a mixed-method systematic review (2024) · cites this paper as Remien et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 105

  1. [1]Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (London, England) 2016; 30(12): 1973– 1983. PMC4949005 27149090
  2. [2]Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. The Lancet HIV 2018; 5(8): e438– e447. 30025681
  3. [3]Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England journal of medicine 2016; 375(9): 830– 839. 27424812 PMC5049503
  4. [7]Aidala AA, Wilson MG, Shubert V, Gogolishvili D, Globerman J, Rueda S, Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review. American journal of public health 2016; 106(1): e1– e23. PMC4695926 26562123
  5. [11]Feller DJ, Agins BD. Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression:A Data Mining Approach. Journal of the International Association of Providers of AIDS Care (JIAPAC) 2017; 16(1): 23– 29. 27629866
  6. [12]Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet (London, England) 2008; 372(9640): 764– 775. 18687460
  7. [15]Hobkirk AL, Towe SL, Lion R, Meade CS. Primary and Secondary HIV Prevention Among Persons with Severe Mental Illness: Recent Findings. Current HIV/AIDS reports 2015; 12(4): 406– 412. 26428958 PMC4812670
  8. [16]Blank MB, Himelhoch SS, Balaji AB, Metzger DS, Dixon LB, Rose CE, A multisite study of the prevalence of HIV with rapid testing in mental health settings. American journal of public health 2014; 104(12): 2377– 2384. 24524493 PMC4133307
  9. [17]Centers for Disease Control and Prevention (CDC). Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008–2012.. In; 2015. PMC4584741 26110835
  10. [18]Himelhoch S, Goldberg R, Calmes C, Medoff D, Slade E, Dixon L, SCREENING FOR AND PREVALENCE OF HIV AND HEPATITIS C AMONG AN OUTPATIENT URBAN SAMPLE OF PEOPLE WITH SERIOUS MENTAL ILLNESS AND CO-OCCURRING SUBSTANCE ABUSE. Journal of community psychology 2011; 39(2): 231– 239. 23543939 PMC3610566
  11. [19]Acuda SW, Sebit MB. Serostatus surveillance testing of HIV-I infection among Zimbabwean psychiatric inpatients, in Zimbabwe. Cent Afr J Med 1996; 42(9): 254– 257. 8997817
  12. [20]Collins PY, Berkman A, Mestry K, Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care 2009; 21(7): 863– 867. 20024743 PMC2800080
  13. [21]Lundberg P, Nakasujja N, Musisi S, Thorson AE, Cantor-Graae E, Allebeck P. HIV prevalence in persons with severe mental illness in Uganda: a cross-sectional hospital-based study. International Journal of Mental Health Systems 2013; 7(1): 20. 23866085 PMC3724693
  14. [22]Maling S, Todd J, Van der Paal L, Grosskurth H, Kinyanda E. HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda. AIDS Care 2011; 23(2): 171– 178. 21259129
  15. [23]Abayomi O, Adelufosi A, Adebayo P, Ighoroje M, Ajogbon D, Ogunwale A. HIV Risk Behavior in Persons with Severe Mental Disorders in a Psychiatric Hospital in Ogun, Nigeria. Annals of medical and health sciences research 2013; 3(3): 380– 384. 24116318 PMC3793444
  16. [24]Bonfils KA, Firmin RL, Salyers MP, Wright ER. Sexuality and intimacy among people living with serious mental illnesses: Factors contributing to sexual activity. Psychiatric rehabilitation journal 2015; 38(3): 249– 255. 25664756 PMC4530100
  17. [25]Guimaraes MD, McKinnon K, Cournos F, Machado CJ, Melo AP, Campos LN, Correlates of HIV infection among patients with mental illness in Brazil. AIDS Care 2014; 26(4): 505– 513. 23998905 PMC4554532
  18. [26]Hariri AG, Karadag F, Gokalp P, Essizoglu A. Risky sexual behavior among patients in Turkey with bipolar disorder, schizophrenia, and heroin addiction. The journal of sexual medicine 2011; 8(8): 2284– 2291. 21492406
  19. [27]Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clinical psychology review 2005; 25(4): 433– 457. 15914265
  20. [29]Smith MD. HIV risk in adolescents with severe mental illness: literature review. Journal of Adolescent Health 2001; 29(5): 320– 329. 11691593
  21. [31]Mangurian C, Cournos F, Schillinger D, Vittinghoff E, Creasman JM, Lee B, Low Rates of HIV Testing Among Adults With Severe Mental Illness Receiving Care in Community Mental Health Settings. Psychiatric services (Washington, DC) 2017; 68(5): 443– 448. 28093055
  22. [32]Meade CS, Sikkema KJ. Voluntary HIV testing among adults with severe mental illness: frequency and associated factors. AIDS and behavior 2005; 9(4): 465– 473. 16323033
  23. [33]Senn TE, Carey MP. HIV testing among individuals with a severe mental illness: review, suggestions for research, and clinical implications. Psychological medicine 2009; 39(3): 355– 363. 18606051 PMC2640447
  24. [34]Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW). AIDS and behavior 2016; 20(7): 1478– 1488. 26078115 PMC4903104
  25. [35]Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study. AIDS and behavior 2016; 20(7): 1527– 1534. 27125241 PMC4912836
  26. [36]Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of general psychiatry 2001; 58(8): 721– 728. 11483137
  27. [37]Do AN, Rosenberg ES, Sullivan PS, Beer L, Strine TW, Schulden JD, Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One 2014; 9(3): e92842. 24663122 PMC3963963
  28. [40]Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. Journal of the International AIDS Society 2013; 16: 18593. 23782478 PMC3687078
  29. [41]Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. Jama 2001; 285(11): 1466– 1474. 11255423
  30. [42]Ingersoll K The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004; 16(2): 199– 211. 14676026
  31. [45]Bhatia MS, Munjal S. Prevalence of Depression in People Living with HIV/AIDS Undergoing ART and Factors Associated with it. Journal of clinical and diagnostic research: JCDR 2014; 8(10): Wc01-04. PMC4253251 25478433
  32. [46]Niu L, Luo D, Liu Y, Silenzio VM, Xiao S. The Mental Health of People Living with HIV in China, 1998–2014: A Systematic Review. PLoS One 2016; 11(4): e0153489. 27082749 PMC4833336
  33. [47]Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC psychiatry 2011; 11: 205. 22208452 PMC3260105
  34. [48]HIV Clinicians Society SA. Management of mental health disorders in HIV-positive patients. 2013 2013; 14(4): 11.
  35. [49]Beckerman NL, Auerbach C. Post-traumatic stress disorder and HIV: a snapshot of co-occurrence. Social work in health care 2010; 49(8): 687– 702. 20853209
  36. [50]Neigh GN, Rhodes ST, Valdez A, Jovanovic T. PTSD co-morbid with HIV: Separate but equal, or two parts of a whole? Neurobiology of disease 2016; 92(Pt B): 116– 123. 26592355 PMC5673262
  37. [51]Sherr L, Nagra N, Kulubya G, Catalan J, Clucas C, Harding R. HIV infection associated post-traumatic stress disorder and post-traumatic growth--a systematic review. Psychology, health & medicine 2011; 16(5): 612– 629. 21793667
  38. [52]Tsao JC, Dobalian A, Moreau C, Dobalian K. Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. The Journal of nervous and mental disease 2004; 192(2): 111– 118. 14770055
  39. [54]Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS and behavior 2017; 21(4): 1138– 1148. 27738780 PMC6089366
  40. [56]Ironson G, Fitch C, Stuetzle R. Depression and survival in a 17-year longitudinal study of people with HIV: Moderating effects of race and education. Psychosomatic Medicine 2017; 79(7): 749– 756. 28498278 PMC8233157
  41. [57]Tsai AC, Bangsberg DR, Frongillo EA, Hunt PW, Muzoora C, Martin JN, Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Social science & medicine (1982) 2012; 74(12): 2012– 2019. 22513248 PMC3348339
  42. [58]Curry A, Latkin C, Davey-Rothwell M. Pathways to depression: the impact of neighborhood violent crime on inner-city residents in Baltimore, Maryland, USA. Social science & medicine (1982) 2008; 67(1): 23– 30. 18396366 PMC2684449
  43. [59]Dowdall N, Ward CL, Lund C. The association between neighbourhood-level deprivation and depression: evidence from the south african national income dynamics study. BMC psychiatry 2017; 17(1): 395. 29228912 PMC5725901
  44. [60]Jones-Rounds ML, Evans GW, Braubach M. The interactive effects of housing and neighbourhood quality on psychological well-being. Journal of epidemiology and community health 2014; 68(2): 171– 175. 24248998
  45. [61]Fialho R, Pereira M, Rusted J, Whale R. Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis. Psychology, health & medicine 2017; 22(9): 1089– 1104. 28100073
  46. [62]Fu X, Lawson MA, Kelley KW, Dantzer R. HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner. J Neuroinflammation 2011; 8: 88. 21810259 PMC3162509
  47. [63]Bird ST, Bogart LM. Perceived race-based and socioeconomic status(SES)-based discrimination in interactions with health care providers. Ethnicity & disease 2001; 11(3): 554– 563. 11572421
  48. [64]Bogart LM, Wagner GJ, Galvan FH, Landrine H, Klein DJ, Sticklor LA. Perceived discrimination and mental health symptoms among Black men with HIV. Cultural Diversity and Ethnic Minority Psychology 2011; 17(3): 295– 302. 21787061 PMC3148695
  49. [65]Dale SK, Bogart LM, Galvan FH, Wagner GJ, Pantalone DW, Klein DJ. Discrimination and Hate Crimes in the Context of Neighborhood Poverty and Stressors Among HIV-Positive African-American Men Who Have Sex with Men. Journal of community health 2016; 41(3): 574– 583. 26696119 PMC4842332
  50. [66]Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. Journal of acquired immune deficiency syndromes (1999) 2007; 44(4): 470– 477. 17179766 PMC6276368
  51. [67]Bemelmans M, Baert S, Negussie E, Bygrave H, Biot M, Jamet C, Sustaining the future of HIV counselling to reach 90–90-90: a regional country analysis. Journal of the International AIDS Society 2016; 19(1): 20751. 27189531 PMC4870383
  52. [68]Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of acquired immune deficiency syndromes (1999) 2011; 58(2): 181– 187. 21857529 PMC3858003
  53. [69]Krumme AA, Kaigamba F, Binagwaho A, Murray MB, Rich ML, Franke MF. Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy. Journal of epidemiology and community health 2015; 69(3): 284– 289. 25385745
  54. [70]Musisi S, Wagner GJ, Ghosh-Dastidar B, Nakasujja N, Dickens A, Okello E. Depression and sexual risk behaviour among clients about to start HIV antiretroviral therapy in Uganda. International journal of STD & AIDS 2014; 25(2): 130– 137. 23970636 PMC3841244
  55. [71]Remien RH, Exner TM, Morin SF, Ehrhardt AA, Johnson MO, Correale J, Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus. AIDS and behavior 2007; 11(5): 663– 675. 17243012
  56. [72]Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Current HIV/AIDS reports 2014; 11(3): 291– 307. 25038748 PMC4359613
  57. [73]Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2009; 48(2): 248– 256. 19072715 PMC2737584
  58. [74]Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (London, England) 2013; 27(16): 2559– 2566. PMC3795966 23770493
  59. [75]Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2013; 57(9): 1309– 1317. 23797288 PMC3792721
  60. [76]Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS medicine 2016; 13(11): e1002183. 27898679 PMC5127502
  61. [77]Kim SH, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS (London, England) 2014; 28(13): 1945– 1956. PMC4162330 24845154
  62. [78]Bucek A, Leu CS, Benson S, Warne P, Abrams EJ, Elkington KS, Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults. The Pediatric infectious disease journal 2018; 37(7): 673– 677. 29227462 PMC5993563
  63. [79]Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. The American journal of psychiatry 2002; 159(10): 1752– 1759. 12359683
  64. [83]Zunszain PA, Hepgul N, Pariante CM. Inflammation and depression. Current topics in behavioral neurosciences 2013; 14: 135– 151. 22553073
  65. [84]Lawson MA, Kelley KW, Dantzer R. Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain, behavior, and immunity 2011; 25(8): 1569– 1575. PMC3191256 21620953
  66. [85]Norcini Pala A, Steca P, Bagrodia R, Helpman L, Colangeli V, Viale P, Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients. Brain, behavior, and immunity 2016; 56: 105– 113. PMC5553322 26883521
  67. [86]Planes R, Bahraoui E. HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS One 2013; 8(9): e74551. 24073214 PMC3779232
  68. [87]Hong S, Banks WA. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain, behavior, and immunity 2015; 45: 1– 12. PMC4342286 25449672
  69. [88]Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 2006; 1(2): 138– 151. 18040780
  70. [89]Boasso A, Hardy AW, Anderson SA, Dolan MJ, Shearer GM. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 2008; 3(8): e2961. 18698365 PMC2491901
  71. [91]Byakwaga H, Boum Y 2nd, Huang Y, Muzoora C, Kembabazi A, Weiser SD, The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. The Journal of infectious diseases 2014; 210(3): 383– 391. 24585899 PMC4148610
  72. [92]Byakwaga H, Hunt PW, Laker-Oketta M, Glidden DV, Huang Y, Bwana BM, The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa. Journal of acquired immune deficiency syndromes (1999) 2015; 70(3): 296– 303. 26181812 PMC4607630
  73. [93]Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. Journal of acquired immune deficiency syndromes (1999) 2014; 65(4): 456– 462. 24220289 PMC3943704
  74. [94]Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. The Journal of infectious diseases 2016; 213(3): 370– 378. 26347573 PMC4704672
  75. [95]Pence BW, Mills JC, Bengtson AM, Gaynes BN, Breger TL, Cook RL, Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States. JAMA psychiatry 2018; 75(4): 379– 385. 29466531 PMC5875308
  76. [96]Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women. American journal of epidemiology 2017; 185(10): 869– 878. 28430844 PMC5430940
  77. [97]Ali G-C, Ryan G, De Silva MJ. Validated Screening Tools for Common Mental Disorders in Low and Middle Income Countries: A Systematic Review. PLOS ONE 2016; 11(6): e0156939. 27310297 PMC4911088
  78. [98]Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression--a systematic review of interventions. Psychology, health & medicine 2011; 16(5): 493– 527. 21809936
  79. [99]Sikkema KJ, Dennis AC, Watt MH, Choi KW, Yemeke TT, Joska JA. Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries. Global mental health (Cambridge, England) 2015; 2. PMC4589870 26435843
  80. [100]van Luenen S, Garnefski N, Spinhoven P, Spaan P, Dusseldorp E, Kraaij V. The Benefits of Psychosocial Interventions for Mental Health in People Living with HIV: A Systematic Review and Meta-analysis. AIDS and behavior 2018; 22(1): 9– 42. 28361453 PMC5758656
  81. [101]Lofgren SM, Nakasujja N, Boulware DR. Systematic Review of Interventions for Depression for People Living with HIV in Africa. AIDS and behavior 2018; 22(1): 1– 8. PMC5823498 28900756
  82. [105]Zuckerbrot RA, Cheung A, Jensen PS, Stein REK, Laraque D. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics 2018; 141(3). 29483200
  83. [106]Cholera R, Pence BW, Bengtson AM, Crane HM, Christopoulos K, Cole SR, Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort. PLoS One 2017; 12(1): e0166435. 28125593 PMC5268441
  84. [107]Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, Underdiagnosis of depression in HIV: who are we missing? Journal of general internal medicine 2003; 18(6): 450– 460. 12823652 PMC1494868
  85. [110]Chibanda D Reducing the treatment gap for mental, neurological and substance use disorders in Africa: lessons from the Friendship Bench in Zimbabwe. Epidemiology and psychiatric sciences 2017; 26(4): 342– 347. 28399952 PMC6998766
  86. [111]Chibanda D Depression and HIV: integrated care towards 90–90-90. International health 2017; 9(2): 77– 79. 28115469 PMC5881265
  87. [113]McKay MM, Chasse KT, Paikoff R, McKinney LD, Baptiste D, Coleman D, Family-level impact of the CHAMP Family Program: a community collaborative effort to support urban families and reduce youth HIV risk exposure. Family process 2004; 43(1): 79– 93. 15359716
  88. [114]Bhana A, McKay MM, Mellins C, Petersen I, Bell C. Family-based HIV prevention and intervention services for youth living in poverty-affected contexts: the CHAMP model of collaborative, evidence-informed programme development. Journal of the International AIDS Society 2010; 13 Suppl 2: S8. 20573290 PMC2890977
  89. [115]Bhana A, Mellins CA, Petersen I, Alicea S, Myeza N, Holst H, The VUKA family program: piloting a family-based psychosocial intervention to promote health and mental health among HIV infected early adolescents in South Africa. AIDS Care 2014; 26(1): 1– 11. 23767772 PMC3838445
  90. [116]Mellins CA, Nestadt D, Bhana A, Petersen I, Abrams EJ, Alicea S, Adapting Evidence-Based Interventions to Meet the Needs of Adolescents Growing Up with HIV in South Africa: The VUKA Case Example. Global social welfare: research, policy & practice 2014; 1(3): 97– 110. PMC4431642 25984440
  91. [117]Pardo G, Saisaengjan C, Gopalan P, Ananworanich J, Lakhonpon S, Nestadt DF, Cultural Adaptation of an Evidence-Informed Psychosocial Intervention to Address the Needs of PHIV+ Youth in Thailand. Global social welfare: research, policy & practice 2017; 4(4): 209– 218. PMC5660129 29104848
  92. [118]Pettifor A, Stoner M, Pike C, Bekker LG. Adolescent lives matter: preventing HIV in adolescents. Current opinion in HIV and AIDS 2018; 13(3): 265– 273. 29528850 PMC5902132
  93. [120]Mellins CA. Promoting mental health in adolescents growing up with HIV. In: International AIDS Conference Amsterdam, Netherlands; 2018.
  94. [122]Wagner GJ, Ngo V, Goutam P, Glick P, Musisi S, Akena D. A Structured Protocol Model of Depression Care versus Clinical Acumen: A Cluster Randomized Trial of the Effects on Depression Screening, Diagnostic Evaluation, and Treatment Uptake in Ugandan HIV Clinics. PLOS ONE 2016; 11(5): e0153132. 27167852 PMC4864192
  95. [123]Haaga DA. Introduction to the special section on stepped care models in psychotherapy. Journal of consulting and clinical psychology 2000; 68(4): 547– 548. 10965628
  96. [124]Abas M, Nyamayaro P, Bere T, Saruchera E, Mothobi N, Simms V, Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa. AIDS and behavior 2018; 22(1): 86– 101. 28063075 PMC5758696
  97. [128]Weiss WM, Murray LK, Zangana GA, Mahmooth Z, Kaysen D, Dorsey S, Community-based mental health treatments for survivors of torture and militant attacks in Southern Iraq: a randomized control trial. BMC psychiatry 2015; 15: 249. 26467303 PMC4605204
  98. [129]Kempf MC, Huang CH, Savage R, Safren SA. Technology-Delivered Mental Health Interventions for People Living with HIV/AIDS (PLWHA): a Review of Recent Advances. Current HIV/AIDS reports 2015; 12(4): 472– 480. 26452644 PMC4853757
  99. [130]Remien RH, Mellins CA, Robbins RN, Kelsey R, Rowe J, Warne P, Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS and behavior 2013; 17(6): 1979– 1991. 23468079 PMC3674110
  100. [131]Andrews G, Williams AD. Up-scaling clinician assisted internet cognitive behavioural therapy (iCBT) for depression: A model for dissemination into primary care. Clinical psychology review 2015; 41: 40– 48. 25043445
  101. [132]Rosso IM, Killgore WD, Olson EA, Webb CA, Fukunaga R, Auerbach RP, Internet-based cognitive behavior therapy for major depressive disorder: A randomized controlled trial. Depression and anxiety 2017; 34(3): 236– 245. 28009467 PMC5540163
  102. [134]Eisinger RW, Fauci AS. Ending the HIV/AIDS Pandemic. Emerging infectious diseases 2018; 24(3): 413– 416. 29460740 PMC5823353
  103. [136]Grant RM, Koester KA. What people want from sex and preexposure prophylaxis. Current opinion in HIV and AIDS 2016; 11(1): 3– 9. 26569183 PMC6446930
  104. [137]Koester K, Amico R, Liu AY, McMahan V, Hosek S, Mayer KH, Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. In: International AIDS Conference Melbourne, Australia.
  105. [138]Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Bernstein KT, HIV Preexposure Prophylaxis as a Gateway to Primary Care. American journal of public health 2018; 108(10): 1418– 1420. 30024802 PMC6137783

Cited by

Sorted by citations

Authors
Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A.
Affiliations
  • New York State Psychiatric Institute (US)
  • National Institutes of Health (US)
Corresponding author
Remien, Robert H.
ORCID
Venue
AIDS
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2019-07-15
Volume
33
Issue
9
Pages
1411-1420
ISSN
0269-9370 (ISSN-L)
DOI
10.1097/qad.0000000000002227
PMC
PMC6635049
OpenAlex
W2945936594
Cited by
727
References
18
Citations by year
2026: 96 · 2025: 136 · 2024: 144 · 2023: 126 · 2022: 101 · 2021: 84 · 2020: 33 · 2019: 5 · 2014: 1 · 2013: 1
FWCI
7.81
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • AIDS (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (T32MH019139, P30MH043520)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
mental health, HIV/AIDS, people living with HIV, substance use, HIV prevention, mental health screening, mental health treatment gap, HIV care continuum, access to mental health care, HIV testing
MeSH terms
Acquired Immunodeficiency Syndrome, Mental Disorders, Humans, Mental Health Services, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review